Quantum BioPharma is trading 5.19% down now at $3.11, with no clear company-specific catalyst identified in available August 26, 2026 overnight coverage.
- Recent company news includes August 21 stock-option grants and August 17 quarterly results.
- The broader market is mixed in pre-market.
- The decline remains unexplained rather than clearly tied to earnings, regulatory news, or a major corporate announcement.